{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:02:24Z","timestamp":1791838944953,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Carol Ann Foundation"},{"name":"Cali Family Foundation, Inc."},{"name":"Vain and Harry Fish Foundation, Inc.,"},{"name":"The Bennett Foundation"},{"DOI":"10.13039\/100004075","name":"Jacob Randall Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004075","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Austrian and Japanese MPS societies"},{"name":"Institutional Development Award"},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30GM114736"],"award-info":[{"award-number":["P30GM114736"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and development","doi-asserted-by":"publisher","award":["JP18gk0110017"],"award-info":[{"award-number":["JP18gk0110017"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mgmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ymgme.2018.03.004","type":"journal-article","created":{"date-parts":[[2018,3,17]],"date-time":"2018-03-17T01:11:20Z","timestamp":1521249080000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Growth impairment in mucopolysaccharidoses"],"prefix":"10.1016","volume":"124","author":[{"given":"Melodie","family":"Melbouci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Fukao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Orii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2018.03.004_bb0005","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001","journal-title":"The Metab. and Mol. Basis of Inherit. Dis."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0010","series-title":"GeneReviews(\u00ae)","article-title":"Mucopolysaccharidosis type I","author":"Clarke","year":"1993"},{"key":"10.1016\/j.ymgme.2018.03.004_bb0015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s12519-014-0517-6","article-title":"Growth patterns in children with mucopolysaccharidosis I and II","volume":"11","author":"R\u00f3\u017cd\u017cy\u0144ska-\u015awi\u0105tkowska","year":"2015","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1542\/peds.2007-1350","article-title":"Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome)","volume":"121","author":"Martin","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.ymgme.2018.03.004_bb0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0030","series-title":"Handbook of Growth and Growth Monitoring in Health and Disease","first-page":"2091","article-title":"Impairment of body growth in mucopolysaccharidoses","author":"Tomatsu","year":"2012"},{"key":"10.1016\/j.ymgme.2018.03.004_bb0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgmr.2017.02.004","article-title":"Birth weight in patients with mucopolysaccharidosis type II: data from the hunter outcome survey (HOS)","volume":"11","author":"Bodamer","year":"2017","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymgmr.2013.10.001","article-title":"Growth charts for patients with hunter syndrome","volume":"1","author":"Patel","year":"2014","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3346\/jkms.2014.29.2.254","article-title":"Impact of enzyme replacement therapy on linear growth in Korean patients with mucopolysaccharidosis type II (Hunter syndrome)","volume":"29","author":"Cho","year":"2014","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0050","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ymgme.2016.01.009","article-title":"The natural history of growth in patients with hunter syndrome: data from the hunter outcome survey (HOS)","volume":"117","author":"Parini","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ymgme.2013.03.001","article-title":"The effect of idursulfase on growth in patients with hunter syndrome: data from the Hunter Outcome Survey (HOS)","volume":"109","author":"Jones","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0060","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10545-013-9658-3","article-title":"Growth in patients with mucopolysaccharidosis type III (Sanfilippo disease)","volume":"37","author":"de Ruijter","year":"2014","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0065","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/ajmg.a.32281","article-title":"Growth charts for patients affected with Morquio A disease","volume":"146A","author":"Monta\u00f1o","year":"2008","journal-title":"Am. J. Med. Genet. Part A"},{"key":"10.1016\/j.ymgme.2018.03.004_bb0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International Morquio A Registry: clinical manifestation and natural course of Morquio A disease","volume":"30","author":"Monta\u00f1o","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1399-0004.1986.tb01262.x","article-title":"Heterogeneity of Morquio disease","volume":"29","author":"Beck","year":"1986","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/8904_2014_333","article-title":"Growth charts for individuals with Mucopolysaccharidosis VI (Maroteaux\u2013Lamy syndrome)","volume":"18","author":"Quartel","year":"2014","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0085","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"Simonaro","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0090","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0095","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.a.30579","article-title":"Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome)","volume":"134A","author":"Swiedler","year":"2005","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.ymgme.2018.03.004_bb0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of sly syndrome (mucopolysaccharidosis type VII)","volume":"53","author":"Monta\u00f1o","year":"2016","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0105","series-title":"Chondroitin and keratan sulfate","first-page":"17","author":"Tomatsu","year":"2015"},{"key":"10.1016\/j.ymgme.2018.03.004_bb0110","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0008-6215(88)80034-X","article-title":"Maintenance of heparan sulfate structure throughout evolution: chemical and enzymic degradation, and 13C-n.M.R.-spectral evidence","volume":"184","author":"Nader","year":"1988","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1590\/S0001-37652009000300007","article-title":"Heparan sulfate proteoglycans: structure, protein interactions and cell signaling","volume":"81","author":"Dreyfuss","year":"2009","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0120","doi-asserted-by":"crossref","first-page":"25R","DOI":"10.1093\/glycob\/cwf066","article-title":"Dermatan sulfate: new functions from an old glycosaminoglycan","volume":"12","author":"Trowbridge","year":"2002","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2018.03.004_bb0125","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-005-5673-3","article-title":"Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses","volume":"28","author":"Tomatsu","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.aca.2016.06.054","article-title":"UPLC-MS\/MS detection of disaccharides derived from glycosaminoglycans as biomarkers of mucopolysaccharidoses","volume":"936","author":"Auray-Blais","year":"2016","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ymgme.2018.03.004_bb0135","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2016.12.010","article-title":"Glycosaminoglycan levels in dried blood spots of patients with mucopolysaccharidoses and mucolipidoses","volume":"120","author":"Kubaski","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0140","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3390\/metabo4030655","article-title":"Establishment of glycosaminoglycan assays for mucopolysaccharidoses","volume":"4","author":"Tomatsu","year":"2014","journal-title":"Metabolites"},{"key":"10.1016\/j.ymgme.2018.03.004_bb0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","article-title":"Therapies for the bone in mucopolysaccharidoses","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10545-012-9522-x","article-title":"Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII","volume":"36","author":"Rowan","year":"2013","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.ymgme.2018.03.004_bb0155","first-page":"1","article-title":"Di-sulfated keratan sulfate as a novel niomarker for mucopolysaccharidosis II, IVA, and IVB","volume":"21","author":"Shimada","year":"2015","journal-title":"JIMD Rep."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218301471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719218301471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T02:45:03Z","timestamp":1719888303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719218301471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1096719218301471"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.03.004","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth impairment in mucopolysaccharidoses","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2018.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}